Liat Hadad Simhayoff
Geen lopende functies
Loopbaan van Liat Hadad Simhayoff
Eerdere bekende functies van Liat Hadad Simhayoff
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALLMED SOLUTIONS LTD | Verkoop & Marketing | 01-03-2010 | - |
| HBL - HADASIT BIO-HOLDINGS LTD | Financieel Directeur/CFO | 01-06-2012 | - |
| TIKCRO TECHNOLOGIES LTD. | Directeur/Bestuurslid | 01-09-2009 | - |
I.B.I Israel Biomedical Innovations Ltd.
 I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Verkoop & Marketing | 01-03-2010 | - |
Opleiding van Liat Hadad Simhayoff
| Tel-Aviv University | Masters Business Admin |
| The Open University | Undergraduate Degree |
Statistieken
Internationaal
| Israël | 6 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Sales & Marketing | 2 |
| Undergraduate Degree | 2 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| ALLMED SOLUTIONS LTD | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
I.B.I Israel Biomedical Innovations Ltd.
I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Health Technology |
Tikcro Technologies Ltd.
 Tikcro Technologies Ltd. BiotechnologyHealth Technology Tikcro Technologies Ltd. operates as a biopharmaceutical company. It pursues an early stage biotechnology project generating new antibodies for cancer treatment addressing immune modulation. This project is based on technology from the Weizmann Institute of Science in Israel. It promotes a new approach for the generation of antibodies which are expected to have selectivity and blocking capabilities and, as a result, are expected to effectively modulate the immune system. Tikcro Technologies was founded on December 14, 1999 and is headquartered in Hadera, Israel. | Health Technology |
